Chief Executive Officer Ian Read took over New York-based Pfizer in 2010, as the company was digesting the 2009 acquisition of Wyeth and preparing for the loss of its top- selling product Lipitor. Photographer: Andrew Harrer/Bloomberg
Chief Executive Officer Ian Read took over New York-based Pfizer in 2010, as the company was digesting the 2009 acquisition of Wyeth and preparing for the loss of its top- selling product Lipitor. Photographer: Andrew Harrer/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=168324961&utmp=%2Fphoto%2F2013-01-15%2Fpfizer-drug-units-shuffle-triggers-concers-about-breakup&utmhn=10.248.179.14&utmac=UA-11413116-12&utmhid=936821358)